News
Faces of Philanthropy: Steve Kaufer
“We have come a long, long way.” When Steve Kaufer’s wife Caroline was diagnosed with neuroendocrine cancer, he began searching for experts who knew about
Faces of Philanthropy:
The Firsty Family
Since 2009, the Firsty Family has organized the Palo Alto Moonlight Walk in honor of Julie Seltzer Firsty. Read more about how their steps have made a difference.
Earning Her Stripes as a Pink Zebra
By the time she was 40 years old, Alicia Gutierrez had earned her stripes as a pink zebra with diagnoses of breast cancer and pancreatic neuroendocrine cancer.
COVID-19 and NETs: What We Now Know
Oncologist Mark Lewis, MD, discusses what we have learned about COVID-19 and NETs in the first six months of the pandemic in this video interview with NETRF CEO Elyse Gellerman.
Making An Everlasting Impact Tribute
NETRF is shining a light on its Everlasting Impact Tribute program, which helps families make a larger impact on NET research with a dynamic program that honors their loved ones.
New NETWise Podcasts on NET Sites
Beginning in August, the NETWise podcast is putting together primary site-specific episodes. NETs can arise almost anywhere in the body, but most start in the gastrointestinal tract, lung, and pancreas.
October 10 Virtual Conference
Check out some of the things we are planning for our October 10th virtual conference for patients and families. We guarantee it’s not your average NET conference. Because you set the agenda!
15-Year NET Survivor Shares His Best Advice
Brian Bowe has weathered many storms: changes in his career, his marriage, and a tragic mass shooting. Looking back, he says one step helped him most in his recovery from neuroendocrine cancer: attending a support group.
Giving USA Report
Annual USA Giving report shows robust philanthropic activity in 2019, paving the way to a strong start for nonprofit giving in 2020.
Potential Prognostic NET Biomarker
Early NETRF-funded research identifies a potential prognostic biomarker to help physicians predict neuroendocrine cancer outcomes.